
Unmet Needs
Learn more




AD Burden on Patients

AD Disease Overview

Epidemiology


Once diagnosed with stage 3 aT1D, patients require lifelong exogenous insulin. This significantly impacts activities of daily living and quality of life, particularly during childhood and adolescence.1-3
.jpg)
